BRAND NAME

GENERI C NAME

CLASSIFICA TION

ACTION

INDICATION

CONTRAIN DICATION

cleocin

CLINDA MYCIN

ANTIINFECT IVE; MACROLIDE ANTIBIOTIC

Macrolide antibiotic produced by a strain of Streptomy ces erythreus. Bacteriostati c or bactericidal, depending on nature of organism and drug concentratio n used.

Acute This drug is 125g/5ml infections contraindicat 0.15ml po caused by ed in q6 sensitive patients with strains of a history of Streptococcu hypersensitiv s ity to pneumoniae, erythromycin Mycoplasma . pneumoniae, Listeria monocytogen Dermatologic es, Legionella : rash, pneumophila alopecia GI: constipatio n,diarrhea, nausea and vomiting, abdominal p ain, hepatitis GU: impotence or decreased libido Hematologic: leucopenia, granulocytop

SIDE EFFECTS/ ADVERSE EFFECTS CNS: headache, malaise, dizziness, somnolence, insomnia, vertigo CV: tachycardia, bradycardia

DOSAG E

NURSING RESPONSIBILITY

Assess patientfor signs andsymptoms of infection Obtain C&S results before beginning therapy Assess for allergic reactions Identify urine output Monitor blood studies Monitorelectrolytes Assess bowelpattern daily Assess for over growth of infection

enia, thrombocyto penia, pancy topenia.

BRAND NAME

GENERIC NAME

CLASSIFICA -TION

ACTION

INDICATION

CONTRAIN DICATION

Apoferrous Ferrous sulfate Gluconate2 ; ApoFerrous Sulfate3; DexFerrum 4 ; DexIron4; Femiron1; Feosol Caplets3; Feosol Tablets3; Feostat1; Feostat Drops1; Fer-In-Sol Drops3; Fer-In-Sol Syrup3; Fer-Iron Drops3;

Anti anemic, Iron supplement

Elevates the serum iron concentratio n which then helps to form High or trapped in the reticuloendot helial cells for storage and eventual conversion to a usable form of iron.

Iron deficiency anemia, hemodialysisinduced (treatment) Sodium ferric gluconate complex injection and iron sucrose injection are indicated for the treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are

Hypersensiti vity Severe hypotension.

SIDE EFFECTS/ ADVERSE EFFECTS Dizziness N&V Nasal Congestion Dyspnea Hypotensio n CHF MI Muscle cramps Flushing checking with physician if black stools occur with other symptoms of internal

DOSAG E

NURSING RESPONSIBILITY

Initial: 300 to 325 mg of regularrelease ferrous sulfate orally once a day.

Advise patient to take medicine as prescribed. Caution patient to make position changes slowly to minimize orhtostatic hypotension. Instruct patient to avoid concurrent use of alcohol or OTC medicine without consulting the physician. Advise patient to consult physician if irregular heartbeat, dyspnea, swelling

Fer-gensol3; Feratab3

receiving supplemental erythropoietin therapy. Iron deficiency anemia (prophylaxis and treatment) Iron supplements are indicated in the prevention and treatment of iron deficiency anemia, which may result from inadequate diet, malabsorptio n, pregnancy, rapid growth during childhood, and/or blood loss. Iron dextran

blood loss Signs of potential side effects, especially abdominal or stomach pain , cramping, or soreness, allergic reaction, backache, flank, groin, or muscle pain, chills, dizziness, fever with increased sweating, headache, metallic taste, nausea or vomiting, numbness, pain, or tingling of hands or feet, chest

of hands and feet and hypotension occurs. Inform patient that angina attacks may occur 30 min. after administration due reflex tachycardia. Encourage patient to comply with additional intervention for hypertension like proper diet, regular exercise, lifestyle changes and stress management.

and iron sorbitol are recommende d for patients in whom iron deficiency has been determined, only after the cause has been corrected, if possible, and only when oral administratio n has been found unsatisfactory or impossible.

pain, hypotensio n, fast heartbeat, flushing or redness of skin, pain and redness or sores at intramuscul ar injection site, redness at intravenous injection site, contact irritation in alimentary tract, diplopia, malaise, or weakness CONTRAIN DICATION DOSAG E NURSING RESPONSIBILITY

BRAND NAME

GENERIC NAME

CLASSIFICA -TION

ACTION

streptomyc in

Streptomyc in sulfate

Antibiotic, anti infective, anti

Binds to 30S ribosomal sub unit,

SIDE EFFECTS/ ADVERSE EFFECTS Intramuscular Pregnancy, Giddiness, Tuberculosis hypersensitiv vertigo, Adult: 15 ity tinnitus,

INDICATION

1 gram/ vial

Draw blood for peak level 1 hour

tubercular

inhibiting protein synthesis in bacterial cell, which causes mis reading of genetic cosd and ultimately cell deathe.

mg/kg daily; max: 1 g daily. Reduce max daily dose to 500750 mg in patients >40 yr. As part of an intermittent therapy: 2530 mg/kg/day 2-3 times/wk; max: 1.5 g/dose. Not >120 g over the course of treatment should be given unless there are no other treatment options. Child: 2040 mg/kg (max: 1 g) daily or 2530 mg/kg (max: 1.5 g) 23 times wkly. Elderly: 60 kg: Dosage

ataxia, hypersensit ivity reactions, ototoxicity and nephrotoxic ity. Potentially Fatal: Anaphylacti c shock, aplastic anaemia and agranulocyt osis. StevensJohnson syndrome and toxic epidermal necrolysis.

I.M injection. Monitor liver and kidney function tests, watch for evidence of hepatotoxici ty and nephrotoxici ty Monitor temp. stay alert for fever and other s/s of super infection Assess neurologic status and sensory function carefully watch closely for neurotoxixit y, seizures Monitor CBC, watch for evidence of blood

reduction is required. Renal impairment: Modification in dose or dosing interval may be required

dyscrasias